Clinical Trials on Prophylactic Anticoagulation in Germany
Total 11 results
-
Goethe UniversityUnknown
-
GWT-TUD GmbHRecruiting
-
University Hospital TuebingenHeart and Diabetes Center North Rhine-WestphaliaUnknownAnticoagulation With NOACGermany
-
BayerJanssen Research & Development, LLC; RTI Health SolutionsCompletedAnticoagulationGermany, United Kingdom, France, Spain
-
University Hospital TuebingenHeart and Diabetes Center North Rhine-WestphaliaRecruitingAnticoagulation With Direct Oral AnticoagulantsGermany
-
Abbott Medical DevicesThoratec Europe LtdCompletedAnticoagulation | Left Ventricular Assist DeviceUnited States, Austria, France, Germany, Czechia
-
Hospira, now a wholly owned subsidiary of PfizerCompletedSolid Tumour | Malignant Haematological Tumour | Primary or Secondary Prophylactic TreatmentGermany
-
University Hospital HeidelbergBristol-Myers Squibb; Boehringer Ingelheim; Daiichi Sankyo, Inc.; University of... and other collaboratorsCompletedCardiovascular Diseases | Vascular Diseases | Ischemic Stroke | Intracerebral Hemorrhage | Oral AnticoagulationGermany
-
Georg NickenigBoehringer IngelheimCompletedAtrial Fibrillation | Oral Anticoagulation | Cardioembolic EventsGermany
-
Insel Gruppe AG, University Hospital BernSahajanand Medical Technologies LimitedRecruitingAtrial Fibrillation (AF) | Oral Anticoagulation | Percutaneous Coronary Intervention (PCI) | P2Y12 InhibitorSpain, France, Switzerland, United Kingdom, Germany, Belgium, Italy, Netherlands, Poland
-
RWTH Aachen UniversityBayerCompletedAtrial Fibrillation or Pulmonary Embolism | Need of Long Term Oral Anticoagulation Therapy (OAT) | Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One LocationGermany